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The continuing presence of the US military in
Iraq and Afghanistan has posed substantial
mental health challenges to US military service
members and mental health care systems.1--7
Much media attention and research effort have
focused on posttraumatic stress disorder (PTSD)
among US servicemen returning from Iraq and
Afghanistan (Operations Iraqi Freedom and Op-
erations Enduring Freedom [OIF/OEF]) and less
on other mental health outcomes. However,
there are other mental health conditions that are
more likely to be diagnosed among the active
duty population, such as a substance use disor-
der, major depression, anxiety, and traumatic
brain injury. Reports by the Mental Health
Advisory Team (MHAT) have noted that the
percentage of soldiers reporting symptoms of
major depression and substance use disorders
has been rising over the years,6,7 and a recent
Rand report pointed out the need to study these
conditions as part of the broad spectrum of
postdeployment mental health consequences.3
Most of the studies on this topic used
convenience samples and focused on soldiers
and Marines, with little attention paid to Navy
and Air Force personnel. Two studies using
convenience samples of soldiers or Marines
returning from Iraq found that about 20% of
these personnel required mental health treat-
ment, 15% had depression, and 10% to 12%
reported having substance use disorder prob-
lems.8,9 Reports by MHAT, also focusing on
soldiers and Marines, noted an increasing rate of
depression and overall mental health problems
over the years, and that the rate was positively
associated with combat level.6,7 A similar finding
was echoed in a recent study using a conve-
nience sample of 1200 soldiers—the authors
found that witnessing atrocities (between rival
Iraqi factions) and experiencing a personal threat
were associated with significantly higher rates
of alcohol misuse.10 The most recent MHAT
report also noted that Army-enlisted personnel
had higher rates of mental health problems than
did Marine-enlisted personnel.6 These studies,
although providing important information on the
prevalence of mental health problems of de-
ployed active duty populations, did not provide
appropriate comparison groups among the non-
deployed. The lack of proper comparison groups
complicated efforts to attribute observed mental
health problems to specific deployment-related
experiences without the capacity to investi-
gate corresponding background rates among
the nondeployed active duty population.
Although PTSD was typically triggered by
witnessing a traumatic event—which was also
part of the criteria for being diagnosed with
the condition—major depression and sub-
stance use disorder could often be triggered
by other events among the nondeployed
population.11
A few studies included the nondeployed
population and had mixed findings. Research
based on the Millennium Cohort Study
(MCS),12,13 which used self-administered surveys
and tracked both active duty personnel and
those separated from the military, compared
health outcomes for those deployed in support of
the Iraq and Afghanistan wars with those not
deployed. The MCS found that men and women
deployed with combat exposure had, respec-
tively, 1.32 and 2.13 times the odds of having
depression compared with those not
deployed14 and found weak evidence of any
impact of a combat deployment on drinking
outcomes among active duty respondents.15
Besides the MCS, 1 study, using a 2008 De-
partment of Defense Health Related Behav-
iors Survey, found that service members with
any combat deployment had significantly
higher rates of heavy alcohol and cigarette
use.16 Finally, a study that examined the
New Jersey Army National Guard members
found previous deployment to be signifi-
cantly linked to a higher rate of major
depression and higher probability of binge
drinking.17
Objectives. Our objective was to analyze the association between deployment
characteristics and diagnostic rates for major depression and substance use
disorder among active duty personnel.
Methods. Using active duty personnel serving between 2001 and 2006 (n=
678382) and deployment information from the Contingent Tracking System, we
identified individuals diagnosed with substance use disorders and major de-
pression from TRICARE health records. We performed logistic regression anal-
ysis to assess the effect of deployment location and length on these diagnostic
rates.
Results. Increased odds of diagnosis with both conditions were associated
with deployment to Iraq or Afghanistan compared with nondeployed personnel
and with Army and Marine Corps personnel compared with Navy and Air Force
personnel. Increases in the likelihood of either diagnosis with deployment length
were only observed among Army personnel.
Conclusions. There were increased substance use disorders and major de-
pression across services associated with combat conditions. It would be impor-
tant to assess whether the public health system has adequate resources to handle
the increasing need of mental health services in this population. (Am J Public
Health. 2012;102:S80–S87. doi:10.2105/AJPH.2011.300425)
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In summary, many earlier investigations
focused just on health needs among the Army
and the Marines. When studies included all
Armed Services, none distinguished between
possible different effects across services.12,14--16
Recent literature on other mental health con-
ditions (in particular, PTSD) found that the
mental health condition rates and the deploy-
ment effects differed across services.6,18 Lastly,
almost all studies relied on self-administered
survey questions to identify mental health prob-
lems, where self-reported answers were subject
to errors and misreporting and could lead to
misdiagnoses of the conditions.
The objective of our study was to analyze,
for each service branch, the association be-
tween deployment characteristics (location and
duration) and the rates of diagnosis for major
depression and substance use disorder among
the active duty population. We examined
a random sample of all active duty enlisted
personnel serving between 2001 and 2006,
focusing on the percentage of personnel di-
agnosed with major depression and substance
use disorder and analyzing the 2 conditions
separately for the 4 military services: Army,
Marines, Navy, and Air Force.
METHODS
We combined several data sources from
TRICARE and the Defense Manpower Data
Center to form the basis of our analysis. First,
we identified the active duty personnel popu-
lation and obtained demographic and service
information (such as age, gender, race, and
rank) from the Defense Enrollment Eligibility
Reporting System (DEERS). Second, we iden-
tified the date that each mental health condi-
tion was first diagnosed and related health
information from the following sources: the
Standard Inpatient Data Record, the Standard
Ambulatory Data Record, and the TRICARE
encounter data from services rendered in
managed care support contracted facilities. The
4 data sources allowed us to capture the
diagnoses from both the inpatient and out-
patient settings and from all civilian and mili-
tary health providers. Third, we did a random
draw for each service from the entire DEERS
database to obtain a 25% sample, and we
linked OIF/OEF deployment characteristics
and military occupational specialty (MOS)
codes between 2001 and 2006 from the
Contingency Tracking System for this sample.
Our data consisted of 678382 unique en-
listed personnel from all services. This repre-
sented roughly a 25% sample of the active
duty population. Among the sample, 49% was
Army, 14% Marine, 20% Navy, and 17% Air
Force. Our sample was representative of the
US Armed Forces active duty enlisted popula-
tion—Appendix A (data available as a supple-
ment to the online version of this article at
http://www.ajph.org) shows the comparison
of key demographic variables and the percent-
age diagnosed with major depression and sub-
stance use disorders between the active duty
population from the 100% DEERS database
and our analytic sample.
Outcome Measures
We analyzed 2 mental health conditions
separately. The dependent variable in the
depression analysis was whether an enlisted
person was diagnosed with major depression
(if the International Classification of Diseases-9
[ICD-9]19 code was either 296.2 or 296.3)
anytime between 2001 and 2006.11 Like-
wise, the substance use disorder analysis
identified persons who were diagnosed with
substance use disorder (if the first 3 digits of
the ICD-9 code was 291 or 292, 303, 304,
305) during the study period. Because we
could only identify conditions through ICD-9
codes, we did not have information on which
type of drugs were identified as the misused
substance.
Statistical Models
Our goal was to provide comparison of
incidences of major depression and substance
use disorders between the nondeployed ser-
vice members and those deployed to certain
locations while controlling for underlying de-
mographic and service characteristics. We
used logistic regression models to assess the
effect of deployment location and duration
under OIF/OEF on the rate of major depres-
sion and substance use disorder within each
service. Our key variables of interest were the
deployment locations and deployment dura-
tions based on information of the last deploy-
ment. For those who were diagnosed with
either mental health condition, “last deploy-
ment” referred to the last deployment before
the service member was diagnosed with the
condition. For example, if a person was di-
agnosed with major depression onMarch 2004
and their most recent deployment before this
date was July 2003, we used deployment
information from the July 2003 deployment.
We provided details of the location and the
duration categories in the following. Covariates
included service affiliation and demographic
characteristics as explained in the following. All
models were estimated using Stata 11.20
Explanatory Variables
There were 3 categories of variables included
in the models: deployment characteristics, ser-
vice characteristics, and demographic informa-
tion. We classified 4 categories of deployment
locations: not deployed under OEF or OIF
(the reference group), deployed to Iraq or Af-
ghanistan, deployed at other known locations
under OEF or OIF (such as Kuwait, Qatar, Saudi
Arabia, Turkey), and deployed to classified or
unknown locations. For duration, we classified
the deployment length into 3 categories: short,
if the length of the last deployment was less than
120 days (the reference group); medium, if
the length was between 120 and 180 days; and
long, if the length was greater than 180 days.
For service characteristics, we included rank
and MOS categories. We categorized MOS
codes into the following categories: combat
arms (reference group), combat support, com-
bat service support, aviation, medical, and
other MOS. The occupational categories were
proxies for potential differences in job stress
that might have influenced a service member’s
probability of being diagnosed with the mental
health conditions, independent of the deploy-
ment effect. We included the following de-
mographic information in the models to control
for potential differences in major depression
and substance use disorder rates across the
demographic dimensions: gender, race/ethnic-
ity (White as the reference group, African
American, Hispanic, Asian, and other races),
marital status, and age. In a sensitivity analysis,
we replaced age with length of service, and the
results were similar between the two specifi-
cations. Lastly, we included year indicators to
control for possible macro trends in major
depression and substance use disorder rates
over the study period in the overall active duty
population.
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RESULTS
Table 1 presents the descriptive statistics of
the sample’s deployment characteristics by
service. The majority of the active duty per-
sonnel were not deployed under OIF/OEF: the
percentages ranged from 62% in the Air Force
to 77% in the Army. Not surprisingly, the
Army and Marines had the highest share of
enlisted members being sent to Iraq and
Afghanistan (12% and 9%, respectively). The
Navy only had 1% of its enlisted personnel
deployed to Afghanistan or Iraq. The Navy had
the highest share of its enlisted population
being deployed to classified or unknown loca-
tions (28%), followed by the Air Force (10%).
The Air Force appeared to serve a more
supportive role, with 23% of their enlisted
population being sent to known OIF/OEF
missions other than Iraq andAfghanistan.
Among those deployed, the Army and Marine
Corps tended to have longer deployments:
58% and 49% of Army and Marine Corps
personnel, respectively, had been deployed
more than 180 days in their most recent
deployment before being included in the sam-
ple, whereas 65% of deployed Air Force
personnel had a tour length of less than 120
days.
Table 2 compares summary statistics of
demographic and service characteristics by
whether the service member was deployed to
OIF/OEF. Although those deployed to OIF/
OEF were similar on most dimensions to the
control group, there were 2 notable
differences: across all services, those deployed
were more likely to be married and in the
middle ranks (pay grade E4 and E5).
Table 3 presents the percentage of the
active duty population who were diagnosed
with each mental health condition by service.
The top of Table 3 reports the rate of sub-
stance use disorder. The overall percentage of
active duty population diagnosed with sub-
stance use disorder (regardless of deployment
status) ranged from 6% in the Marine Corps to
9% in the Navy. Among the population di-
agnosed with a substance use disorder, 30%
were because of alcohol use and 70% were
because of drug use (see Appendix A; avail-
able online at http://www.ajph.org). In addi-
tion, 6% and 4% had major depression and
PTSD as comorbid conditions, respectively
(results not shown in Table 3). Deployment
to Afghanistan and Iraq increased the inci-
dence of substance use disorder substantially
among Army and Marines Corps personnel:
the rate of substance use disorder more than
doubled in the Army (14.5% among those
deployed to Afghanistan or Iraq vs 6% among
the nondeployed; P < .001 in pairwise com-
parison) and almost doubled in the Marine
Corps (9.3% vs 5%; P < .001). Among the
small share of Navy personnel sent to Afgha-
nistan or Iraq, their rate of substance use
disorder diagnoses was comparable to the
nondeployed Navy enlisted. A total of 7% of
Air Force enlisted deployed to Iraq and
Afghanistan were diagnosed with substance
use disorder compared with 6% among the
nondeployed population. Across all services,
those deployed to other nonclassified OIF/
OEF missions had similar substance use dis-
order rates as those deployed to Iraq or
Afghanistan. Among Army and Air Force
personnel, those deployed to classified or un-
known locations actually had lower substance
use disorder rates than did the nondeployed
group. Lastly, among Army soldiers deployed
under OIF/OEF, the substance use disorder
rate, which was higher than that in the other
3 services, increased as the tour length in-
creased. We did not observe this trend in the
other 3 services.
The bottom of Table 3 reports the rates of
major depression by the service. The overall
rate of major depression was much lower than
that of substance use disorder: it ranged from
1.7% for the Marines Corps to 3.3% for the Air
Force. However, major depression was more
likely to be accompanied by other comorbid
conditions; 25% had substance use disorder as
a comorbid condition and 18% had PTSD
(results not shown in Table 3). The rate of
major depression was substantially higher in
the population deployed to Iraq, Afghanistan,
or other known nonclassified locations under
OIF/OEF compared with the nondeployed
population. The rate of major depression did
not appear to substantially differ across differ-
ent deployment durations.
Table 4 presents results from the logistic
regressions in terms of odds ratios (ORs) and
focuses only on the effect of deployment
characteristics (the complete results for all
TABLE 1—Descriptive Statistics of Enlisted Personnel Deployment Characteristics, by Military Service Branch: 2001–2006
Deployment characteristics Army, No. (%) or No. Marines, No. (%) or No. Navy, No. (%) or No. Air Force, No. (%) or No.
Location of last OIF/OEF deployment
Not deployed under OIF/OEF 257873 (77%) 73995 (75%) 86 754 (65%) 69790 (62%)
Deployed to Afghanistan or Iraq 39193 (12%) 8633 (9%) 1366 (1%) 5922 (5%)
Deployed to other nonclassified location 29800 (9%) 11586 (12%) 8556 (6%) 25470 (23%)
Deployed to classified or unknown location 6682 (2%) 4310 (4%) 37 339 (28%) 11113 (10%)
Duration of last OIF/OEF deployment among those that deployed
Short (1–120 d) 91885 (28%) 25011 (25%) 42 106 (31%) 72892 (65%)
Medium (120–180 d) 46898 (14%) 25644 (26%) 31 390 (23%) 27590 (25%)
Long (more than 180 d) 194796 (58%) 47884 (49%) 60 499 (45%) 11837 (11%)
Sample size 333548 98524 134015 112295
Note. OIF/OEF=Operations Iraqi Freedom and Operations Enduring Freedom.
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variables are included in the Appendix, avail-
able online at http://www.ajph.org). The top of
Table 4 shows that deployment under OIF/
OEF significantly increased the odds of having
a substance use disorder compared with those
not deployed, although the magnitude varied
somewhat across the services and locations.
Among Army enlisted personnel, the odds of
being diagnosed with substance use disorder
was 4.05 times higher among those deployed
to Iraq/Afghanistan than it was among those
not deployed under OIF/OEF (95% confi-
dence interval [CI]=3.82, 4.30). Being
deployed on other known OIF/OEF missions
also increased the odds of having a substance
use disorder by the same magnitude (OR=
3.72; 95% CI=3.53, 3.93). Being deployed to
a classified or unknown location (2% of the
Army enlisted) increased the odds by a much
smaller magnitude, although the effect was
still highly significant (OR=1.26; 95% CI=
1.12,1.41). The effects of being deployed to
Iraq or Afghanistan and on other known OIF/
OEF missions were comparable for the Ma-
rines; the odds of developing PTSD increased
by 4.36 (95% CI=3.82, 4.97) and 3.12 (95%
CI=2.79, 3.48), respectively. Deployment to
a classified or unknown location carried similar
odds as the other locations for the enlisted
Marines (OR=3.03; 95% CI=2.65, 3.47).
The effect of deployment location was much
smaller for the Navy and the Air Force. For
both, being deployed to Iraq or Afghanistan
increased the odds of developing a substance
use disorder by 1.8 times (95% CI=1.56,
1.99) compared with those not deployed under
OIF/OEF. For Navy personnel, being deployed
to OIF/OEF locations other than Afghanistan
or Iraq carried similar odds of having a sub-
stance use disorder (OR=1.94; 95% CI=1.78,
2.12 and OR=1.82; 95% CI=1.71, 1.94, for
known and classified locations, respectively).
TABLE 2—Descriptive Statistics of Enlisted Personnel Demographic and Service Characteristics, by Military Service Branch
and Deployment Status to OIF/OEF: 2001–2006



















Male 88% 89% 96% 97% 86% 87% 82% 85%
Female 12% 11% 4% 3% 14% 13% 18% 15%
Marital status
Single 57% 42% 74% 54% 60% 47% 54% 39%
Married 43% 58% 26% 46% 40% 53% 46% 61%
Race
White 65% 61% 72% 68% 59% 55% 75% 73%
Black 19% 22% 10% 11% 21% 23% 15% 16%
Hispanic 7% 6% 8% 10% 7% 8% 3% 4%
Asian 4% 3% 3% 3% 6% 6% 2% 2%
Other races 6% 7% 7% 8% 8% 8% 5% 5%
Age 27 29 23 25 26 28 27 31
Service characteristics
Military occupational specialty
Combat arms 28% 28% 37% 38% 5% 5% 10% 10%
Combat support 11% 9% 16% 16% 9% 10% 0% 0%
Combat service support 26% 23% 27% 25% 5% 5% 75% 79%
Aviation 14% 15% 3% 3%
Medical 10% 10% 3% 2%
Other military occupational specialty 26% 30% 5% 5% 75% 74% 14% 10%
Rank
E1–E3 41% 10% 70% 38% 48% 23% 45% 12%
E4 26% 37% 13% 30% 17% 25% 16% 24%
E5 15% 25% 9% 18% 17% 26% 19% 30%
E6 10% 16% 5% 7% 12% 17% 11% 19%
E7–E9 7% 11% 4% 7% 6% 10% 9% 16%
Sample size 294814 88614 80373 27275 97378 52821 84285 51149
Note. OIF/OEF=Operations Iraqi Freedom and Operations Enduring Freedom.
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For the Air Force, deployments to nonclassi-
fied locations increased the risk of having
a substance use disorder by 1.62 times (95%
CI=1.51, 1.75), but deployments to a classi-
fied or unknown location did not affect the risk
of having a substance use disorder.
Deployment duration appeared to be asso-
ciated with substance use disorder diagnoses
only among Army personnel. Compared with
those who had a short tour length (<120 days),
Army soldiers whose last deployment was
between 120 and 180 days were 1.08 times
more likely to be diagnosed later with sub-
stance use disorder (95% CI=1.00, 1.16), and
those whose last deployment was more than
180 days had an OR of 1.31 (95% CI=1.24,
1.39). A long deployment duration did not
significantly increase the odds of having a sub-
stance use disorder for the other 3 services.
Although not the focus of this study, it was
worth highlighting results of a few demo-
graphic and service variables. Appendix B
(available as a supplement to the online article
at http://www.ajph.org) shows that among the
broad categories of MOS, enlisted personnel
whose specialty was in the category combat
arms had the highest odds of developing
a substance use disorder. In general, being in
a lower rank was associated with higher odds of
having a substance use disorder, as was being
White (compared with other racial/ethnic
groups).
Table 4 shows the results from the major
depression analysis (full results in Appendix
C, available as a supplement to the online
version of the article at http://www.ajph.org).
Deployment to Iraq or Afghanistan was asso-
ciated with higher odds of major depression.
The highest OR was observed for the Marines
(OR=4.51; 95% CI=3.66, 5.57), and the
lowest OR was observed for the Air Force
(OR=1.45; 95% CI=1.22, 1.72). Deploy-
ments to other nonclassified locations were also
associated with higher odds of major depression,
although the magnitude was lower for the Navy
(OR=3.25; 95% CI=2.5, 4.22, for deployment
to Afghanistan and Iraq; OR=1.92; 95% CI=
1.64, 2.24 for nonclassified locations). The
ORs for classified or unknown locations were
lower (OR ranged from 0.97 to 2 depending on
the service), although these were still statistically
significant for all services, except for the Air
Force. Another result worth highlighting was
that women had a much higher odds of de-
veloping major depression compared with men
(see Appendix C, available online at http://
www.ajph.org): the OR ranged from 4.04 for the
Army to 7.71 for the Marines. Similarly, being
married was also associated with a higher risk
of major depression across all services. Lastly,
in a sensitivity analysis, we analyzed alcohol and
drug use disorders separately and found simi-
larly strong associations between deployment
location and either condition (Appendix D,
available as a supplement to the online version
of the article at http://www.ajph.org).
TABLE 3—Actual Percentage of Personnel Diagnosed With Substance Use Disorder and Major Depression, by
Military Service Branch and Deployment Location and Length: 2001–2006
Army, %,
% (95% CI), or No.
Marines, %,
% (95% CI), or No.
Navy, %,
% (95% CI), or No.
Air Force, %,
% (95% CI), or No.
Overall % diagnosed with substance use disorder 7.6% 6.0% 8.8% 6.1%
Based on location of last OIF/OEF deployment
Not deployed under OIF/OEF 6.0 (6.0, 6.1) 5.0 (4.9, 5.2) 8.0 (7.8, 8.2) 5.9 (5.8, 6.1)
Deployed to Afghanistan or Iraq 14.8 (14.4,15.1) 9.3 (8.7, 9.9) 8.6 (7.2,10.2) 7.1 (6.5, 7.8)
Deployed to other nonclassified location 13.4 (13.0, 3.8) 8.6 (8.1, 9.2) 10.4 (9.8, 11.1) 7.1 (6.7, 7.4)
Deployed to classified or unknown location 4.9 (4.4,5.4) 8.7 (7.9, 9.6) 10.4 (10.1,10.8) 4.3 (3.9, 4.7)
Based on duration of Last OIF/OEF deployment
Short (1–120 d) 11.2 (11.0, 11.9) 9.7 (9.0,10.5) 10.3 (9.8, 10.8) 6.1 (5.8, 6.3)
Medium (120–180 d) 12.6 (12.3, 13.5) 8.2 (7.6, 8.9) 10.9 (10.4, 11.5) 7.0 (6.5, 7.5)
Long (more than 180 d) 14.4 (14.1, 14.7) 8.8 (8.3, 9.3) 10.2 (9.8, 10.6) 6.5 (5.8,7.2)
Overall % diagnosed with major depression 2.5% 1.7% 2.4% 3.3%
Based on location of last OIF/OEF deployment
Not deployed under OIF/OEF 1.7 (1.7, 1.8) 1.2 (1.1, 1.2) 2.2 (2.1, 2.3) 3.1 (3.0, 3.3)
Deployed to Afghanistan or Iraq 5.1 (4.9, 5.3) 3.8 (3.4, 4.2) 5.8 (4.6, 7.0) 3.5 (3.0, 4.0)
Deployed to other nonclassified location 5.7 (5.5, 6.0) 3.6 (3.2, 3.9) 3.5 (3.1, 3.9) 3.9 (3.6, 4.1)
Deployed to classified or unknown location 2.5 (2.2, 2.9) 2.3 (1.8, 2.7) 2.4 (2.3, 2.6) 2.3 (2.1, 2.6)
Based on duration of last OIF/OEF deployment
Short (1–120 d) 4.6 (4.4, 5.0) 3.6 (3.1, 4.1) 2.7 (2.4, 3.0) 3.3 (3.1, 3.5)
Medium (120–180 d) 4.5 (4.2, 5.0) 3.5 (3.0, 3.9) 2.8 (2.5, 3.1) 3.8 (3.4, 4.2)
Long (more than 180 d) 5.4 (5.3, 5.7) 3.3 (3.0, 3.6) 2.7 (2.5, 2.9) 3.5 (3.0, 4.1)
Sample size 333548 98524 134015 112295
Note. OIF/OEF=Operations Iraqi Freedom and Operations Enduring Freedom.
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DISCUSSION
In this study, we found that in general,
deployment under OIF/OEF increased the
risks of being diagnosed with both substance
use disorder and major depression substan-
tially, although the magnitudes of the effects
varied somewhat across services and across
deployment locations. Deployment length, by
contrast, was not strongly associated with these
2 mental health conditions, except among
Army personnel. However, even in that case,
the magnitude of the effect was much smaller
than the magnitude of the effect because of
deployment locations.
Our study provided valuable insight for the
mental health readiness of the US Armed
Services and implications for potential, contin-
ued support of ongoing operations and their
post deployment health care needs. The Mili-
tary Health System is currently a key focal
point of military budget reviews; therefore, this
study contributed important information to
identify the need for sustained support of the
services.
This study had a few limitations. First, our
data did not allow for assessment of level of
combat exposure. Therefore, we were unable
to ascertain whether the adverse effect was
because of deployment to a combat zone itself
or because of direct combat exposure. We
instead used the deployment location of Iraq
and Afghanistan as a proxy for higher levels of
combat stress, because troops deployed to OEF
and OIF had increased likelihood of combat
exposures compared with other deployed
populations.3
Second, although we were able to include
MOS, we did not have details on the specific
assignments for any given deployment. Such
details on assignment might provide additional
insight on the underlying causes of adverse
effects of deployments. Third, although our
sample was representative of those who ever
served in the US Armed Forces between 2001
and 2006, we most likely missed the more
severe cases of the mental health conditions
because those would show up in the VA system
unless they were first diagnosed inside the
TRICARE system. As a result, our overall
percentages of major depression and substance
use disorders understated the overall preva-
lence of the conditions, especially among
the veteran population. Fourth, although we
had the full deployment information of OIF/
OEF missions, we were unable to capture
other missions (e.g., those deployed to non-
OIF/OEFmissions, such as deployment to Haiti
or Cuba, who would be in our control group).
This likely made our estimated effects of de-
ployment a conservative estimate, because the
actual rate of major depression and substance
use disorder was likely lower in the strictly
nondeployed population.
Third, our sample was representative of all
active duty personnel who served in the US
Armed Forces between 2001 and 2006, in-
cluding those who left the service but were
eligible for TRICARE coverage for some part of
the study period. TRICARE is the health care
system of the Department of Defense that
serves all uniformed services, activated Na-
tional Guard and Reserve, retired military, and
their families worldwide. Service members
are automatically eligible for and enrolled in
TRICARE when they remain on active duty.
When veterans are separated from the military
under other than dishonorable conditions,
their health care is no longer provided by
TRICARE but provided by the Department
of Veterans Affairs (VA) health care system.
Although we captured mental health status
among recent veterans to include those who
had diagnosed mental health problems while
TABLE 4—Effect of Last Deployment’s Location and Duration on the Rate of Substance Use Disorder and Major Depression, 2001–2006
Army, OR (95% CI) Marines, OR (95% CI) Navy, OR (95% CI) Air Force, OR (95% CI)
Substance use disorder
Location of last deployment (reference group is not deployed under OIF/OEF)
Deployed to Afghanistan or Iraq 4.05*** (3.82, 4.30) 4.36*** (3.82, 4.97) 1.77*** (1.45, 2.16) 1.76*** (1.56, 1.99)
Deployed to other nonclassified location 3.72*** (3.53, 3.93) 3.12*** (2.79, 3.48) 1.94*** (1.78, 2.12) 1.62*** (1.51, 1.75)
Deployed to classified or unknown location 1.26*** (1.12, 1.41) 3.03*** (2.65, 3.47) 1.82*** (1.71, 1.94) 1.05 (0.94,1.16)
Duration of last deployment (reference group is short [ < 120 d])
Medium (120–180 d) 1.08** (1.00,1.16) 0.82*** (0.73, 0.93) 1.12*** (1.03, 1.21) 1.16*** (1.05,1.27)
Long (longer than 180 d) 1.31*** (1.24, 1.39) 0.92 (0.82,1.03) 1.06* (0.99, 1.14) 1.11 (0.97,1.27)
Major depression
Location of last deployment (reference group is not deployed under OIF/OEF)
Deployed to Afghanistan or Iraq 3.52*** (3.21, 3.86) 4.51*** (3.66, 5.57) 3.25*** (2.50, 4.22) 1.45*** (1.22,1.72)
Deployed to other nonclassified location 3.91*** (3.60, 4.24) 3.13*** (2.62, 3.74) 1.92*** (1.64, 2.24) 1.50*** (1.36,1.66)
Deployed to classified or unknown location 1.56*** (1.32, 1.83) 2.00*** (1.57, 2.55) 1.39*** (1.22, 1.57) 0.97 (0.84,1.11)
Duration of last deployment (reference group is short [ < 120 d])
Medium (120–180 d) 0.94 (0.84, 1.05) 1.01 (0.83, 1.23) 1.03 (0.88,1.20) 1.20*** (1.06,1.37)
Long (longer than 180 d) 1.20*** (1.10, 1.30) 0.89 (0.74, 1.07) 0.98 (0.86,1.12) 1.16* (0.97,1.38)
Sample size 333548 98524 134015 112295
Note. OIF/OEF=Operations Iraqi Freedom and Operations Enduring Freedom.
*P< .1; **P< .05; ***P< .01.
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on active service, this was not a study of the
general veteran population who were diag-
nosed in the VA health care system after
separation from service. Although the military
has implemented educational programs to re-
duce the amount of stigma associated with
mental illness, such as the Army Campaign Plan
for Health Promotion, Risk Reduction and
Suicide Prevention, and the Suicide Prevention
Council, our study could not address the extent
to which mental health conditions remained
undiagnosed among the active duty population
who avoided seeking mental health treatment
because of the stigma surrounding their illness.
Last, using clinical diagnoses likely under-
estimated the true rate of depression and sub-
stance use disorders among the active duty
population because of underreporting as a re-
sult of the stigma associated with seeking
mental health treatment—24% of enlisted
members from OEF surveyed by MHAT in
2009 believed that seeking mental health care
services would harm their careers (30% among
those serving in OIF), and 30% among those
in OEF (40% in OIF) believed that it would
result in differential treatment by unit leader-
ship and lost of confidence by unit mem-
bers.21,22 The degree of underreporting might be
higher among those not deployed, because the
deployed personnel were required to complete
the Post-Deployment Health Assessment
(PDHA), which screened for mental health
problems and made referrals for treatment if
needed. However, we did not expect the degree
of underreporting to introduce any significant
bias in our estimates for several reasons. For one,
PDHA is administered to all deployed personnel,
not just those deployed to OIF/OEF, so some
of our control groups were also subject to the
screening process. In addition, although PDHA
was designed to screen for potential PTSD cases,
it was not designed to explicitly screen for major
depression and substance use disorder. Before
the PDHA revision in April 2007, there was only
1 question related to depression as part of the
PTSD screening, and 1 question related to
whether a person was interested in receiving
help for an alcohol problem.
With these caveats in mind, it was useful to
compare our results to those from the MCS—
the other major research effort that tracked
population-based military cohort’s health out-
comes using self-administered surveys. It was
not surprising that our overall rates of de-
pression and substance use disorder because of
alcohol were lower than those reported in MCS,
because MCS identified conditions through
surveys, whereas we identified conditions
through TRICARE health records. The overall
rate of new onset of depression in MCS was 4%
(Wells et al14; Tables 2 and 3), whereas our
overall rate of major depression was 2% (see the
online appendixes, available at http://www.ajph.
org). Note, however, MCS used screening ques-
tions that captured a broader spectrum of de-
pression, whereas our clinical diagnoses were
limited to just major depression. MCS did not
have measures to capture drug use disorders, but
reported percentages of respondents with drink-
ing problems. By contrast, our analysis found
amuch higher OR associated with deployment to
Afghanistan or Iraq (i.e., deployed with combat
exposures) for both conditions compared with
the MCS findings.14,15
It was not surprising that deployment to
Iraq and Afghanistan increased the odds of
major depression and substance use disorders
among service members, given that the com-
bat exposure levels in those 2 locations were
much higher in other locations. The magni-
tude of the adverse effect, however, was sub-
stantial, especially among those engaged in
ground battle. The fact that we observed the
largest adverse effect of deployment locations
among Army and Marines likely reflected the
different levels of direct combat exposure
across services. Our calculations from the
PDHA from the same time period showed that
Army and Marine enlisted members had
a much higher rate of seeing individuals killed
during deployment or being inside destroyed
vehicles compared with the Navy and Air
Force. Other studies using the PDHA also
documented that the majority of physical
injuries from OIF occurred among Marine
Corps personnel, followed by the Army.23The
lower odds associated with classified location
deployments might be caused by selection: those
who were selected for covert operations might
have been originally selected partly for having
a stronger mental health readiness than the
general deployed population; furthermore, they
might have undergone better preparation and
training. However, it was important to note that
even among those deployed to the classified or
unknown locations, the rate of both having
a substance use disorder and major depression
was still higher than that of the nondeployed
population. The study also revealed a substan-
tially higher risk of major depression among the
female enlisted personnel, especially in the Ma-
rine Corps. This finding was consistent with
previous literature that found that women had
a higher likelihood of reporting symptoms of
depression.12,24,25 We could not ascertain, how-
ever, whether this might be because women
more actively sought treatment of the depression
symptoms, or that they were more likely to
develop major depression in the military envi-
ronment. However, evidence on gender and
depression suggested that women were not more
likely to seek treatment.25
Major depression and substance use disor-
ders both require long-term treatment, and
pose a substantial health care cost as well as
psychological and social costs to the individual
and society.3,26,27 It is important for future
research to link actual detailed combat expe-
rience and intensity to clinical data to better
identify the types of combat experiences and
environments that are triggers for these men-
tal health conditions. Such insight would con-
tribute to the design of training programs that
can better mentally prepare the enlisted for
their deployment assignments. Given the
continuing US military presence in Afghani-
stan and other parts of the world, and the
increasing trend in major mental health con-
ditions reported in the US military, it would be
important for the Department of Defense to
assess whether the current system has ade-
quate resources and manpower to handle the
increasing number of active duty personnel
who need mental health services. j
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